Good article by Andrew Lack in the December 23 New York Times about Amgen’s vulnerabilities to attack on their near monopoly over anemia drugs. Click here to read the article.
Creative awards are meaningless if you can’t convert them into revenue, profit and market share. Click here to learn more about vSente. We wage and win battles for market share.